Variability in nose-to-lung aerosol delivery

Journal of Aerosol Science

Volumn 78, Issue , 2014, Pages 11-29

  Walenga, Ross L ^a   Tian, Geng ^a   Hindle, Michael ^b   Yelverton, Joshua ^b   Dodson, Kelley ^b   Longest, P Worth ^a,b  

^a Virginia Commonwealth University   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Controlled condensational growth; Excipient enhanced growth; Nasal aerosol deposition; Nasal variability; Respiratory drug delivery; Submicrometer aerosols

Indexed keywords

AEROSOLS; ATMOSPHERIC MOVEMENTS; BIOLOGICAL ORGANS; COMPUTATIONAL FLUID DYNAMICS; COMPUTERIZED TOMOGRAPHY; DEPOSITION; RESPIRATORY MECHANICS; STATISTICAL METHODS; TARGETED DRUG DELIVERY;

AEROSOL DEPOSITION; CONDENSATIONAL GROWTH; ENHANCED GROWTH; NASAL VARIABILITY; RESPIRATORY DRUG DELIVERIES; SUBMICROMETERS;

CONTROLLED DRUG DELIVERY;

AEROSOL; CONFIDENCE INTERVAL; DEPOSITIONAL ENVIRONMENT; DRUG; HYDRAULICS; RESPIRATORY DISEASE; SENSORY SYSTEM; STEADY FLOW; TOMOGRAPHY;

ADULT; AEROSOL; ARTICLE; COMPUTATIONAL FLUID DYNAMICS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; EXCIPIENT ENHANCED GROWTH; FEMALE; FLOW RATE; GEOMETRY; HUMAN; HYDRAULIC PERMEABILITY; IN VITRO STUDY; INHALATIONAL DRUG ADMINISTRATION; LUNG; MALE; NASAL CANNULA; NASOPHARYNX; NOSE; NOSE AIRFLOW; NOSE CAVITY; PARTICLE SIZE; PHYSICAL PHENOMENA; PREDICTION; SIMULATION; STEADY STATE;

EID: 84908575210     PISSN: 00218502     EISSN: 18791964     Source Type: Journal    
DOI: 10.1016/j.jaerosci.2014.08.003     Document Type: Article

References (76)

1. Aboussouan L.S., Ricaurte B. Noninvasive positive pressure ventilation: increasing use in acute care. Cleveland Clinical Journal of Medicine 2010, 77:307-316.
2. Ari A., Harwood R., Sheard M., Dailey P., Fink J.B. in vitro comparison of heliox and oxygen in aerosol delivery using pediatric high flow nasal cannula. Pediatric Pulmonology 2011, 46:795-801.
3. Bennett W.D., Zeman K.L. Effect of race on fine particle deposition for oral and nasal breathing. Inhalation Toxicology 2005, 17:641-648.
4. Bhashyam A.R., Wolf M.T., Marcinkowski A.L., Saville A., Thomas K., Carcillo J.A., Corcoran T.E. Aerosol delivery through nasal cannulas: an in vitro study. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2008, 21:181-187.
5. Borgstrom L., Olsson B., Thorsson L. Degree of throat deposition can explain the variability in lung deposition of inhaled drugs. Journal of Aerosol Medicine 2006, 19:473-483.
6. Brochard L., Mancebo J., Wysocki M., Lofaso F., Conti G., Rauss A., Simonneau G., Benito S., Gasparetto A., Lemaire F., Isabey D., Harf A. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. New England Journal of Medicine 1995, 333:817-822.
7. Carrigy N.B., Ruzycki C.A., Golshahi L., Finlay W.H. Pediatric in vitro and in silico models of deposition via oral and nasal inhalation. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2014, 27:149-169.
8. Cheng Y.S. Aerosol deposition in the extrathoracic region. Aerosol Science and Technology 2003, 37:659-671.
9. Clark A.R., Hartman M.S. Regional lung deposition: can it be controlled and have an impact on safety and efficacy?. Respiratory Drug Delivery 2012, 2012(1):89-100.
10. Dhand R. Aerosol therapy in patients receiving noninvasive positive pressure ventilation. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2012, 25:63-78.
11. Finlay W.H. Estimating the type of hygroscopic behavior exhibited by aqueous droplets. Journal of Aerosol Medicine 1998, 11:221-229.
12. Garcia G.J.M., Tewksbury E.W., Wong B.A., Kimbell J.S. Interindividual variability in nasal filtration as a function of nasal cavity geometry. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2009, 22:139-155.
13. Golshahi L., Noga M.L., Thompson R.B., Finlay W.H. in vitro deposition measurement of inhaled micrometer-sized particles in extrathoracic airways of children and adolescents during nose breathing. Journal of Aerosol Science 2011, 42:474-488.
14. Golshahi L., Noga M.L., Finlay W.H. Deposition of inhaled micrometer-sized particles in oropharyngeal airway replicas of children at constant flow rates. Journal of Aerosol Science 2012, 49:21-31.
15. Golshahi L., Tian G., Azimi M., Son Y.-J., Walenga R.L., Longest P.W., Hindle M. The use of condensational growth methods for efficient drug delivery to the lungs during noninvasive ventilation high flow therapy. Pharmaceutical Research 2013, 30:2917-2930.
16. Golshahi, L., Longest, P.W., Azimi, M., Syed, A., Hindle, M. (2014). Intermittent aerosol delivery to the lungs during high flow nasal cannula therapy, Respiratory Care (in press). http://dx.doi.org/10.4187/respcare.02903.
17. Grgic B., Finlay W.H., Burnell P.K.P., Heenan A.F. in vitro intersubject and intrasubject deposition measurements in realistic mouth-throat geometries. Journal of Aerosol Science 2004, 35:1025-1040.
18. Guilmette R.A., Cheng Y.S., Yeh H.C., Swift D.L. Deposition of 0.005-12μm monodisperse particles in a computer-milled, MRI-based nasal airway replica. Inhalation Toxicology 1994, 6(Suppl. 1):395-399.
19. Heyder J., Rudolf G. Deposition of aerosol particles in the human nose. Inhaled Particles 1975, 4:107-126.
20. Hindle M., Longest P.W. Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model. Pharmaceutical Research 2010, 27:1800-1811.
21. Hindle M., Longest P.W. Condensational growth of combination drug-excipient submicrometer particles for targeted high efficiency pulmonary delivery: evaluation of formulation and delivery device. Journal of Pharmacy and Pharmacology 2012, 64:1254-1263.
22. Hounam R.F., Black A., Walsh M. The deposition of aerosol particles in the nasopharyngeal region of the human respiratory tract. Aerosol Science 1971, 2:47-61.
23. Inthavong K., Ge Q.J., Se C.M.K., Yang W., Tu J.Y. Simulation of sprayed particle deposition in a human nasal cavity including a nasal spray device. Journal of Aerosol Science 2011, 42:100-113.
24. Kelly J.T., Asgharian B., Kimbell J.S., Wong B. Particle deposition in human nasal airway replicas manufactured by different methods. Part II: ultrafine particles. Aerosol Science and Technology 2004, 38:1072-1079.
25. Kelly J.T., Asgharian B., Kimbell J.S., Wong B. Particle deposition in human nasal airway replicas manufactured by different methods. Part I: inertial regime particles. Aerosol Science and Technology 2004, 38:1063-1071.
26. Kesavanathan J., Bascom R., Swift D.L. The effect of nasal passage characteristics on particle deposition. Journal of Aerosol Medicine 1998, 11:27-39.
27. Kimbell J.S., Segal R.A., Asgharian B., Wong B.A., Schroeter J.D., Southall J.P., Dickens C.J., Brace G., Miller F.J. Characterization of deposition from nasal spray devices using a computational fluid dynamics model of the human nasal passages. Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung 2007, 20:59-74.
28. Kuhli M., Weiss M., Steckel H. A sampling and dilution system for droplet aerosols from medical nebulisers developed for use with an optical particle counter. Aerosol Science 2009, 40:523-533.
29. Lang C., Grützenmacher S., Mlynski B., Plontke A., Mlynski G. Investigating the nasal cycle using endoscopy, rhinoresistometry, and acoustic rhinometry. The Laryngoscope 2003, 113:284-289.
30. Lee J.H., Rehder K.J., Williford L., Cheifetz I.M., Turner D.A. Use of high flow nasal cannula in critically ill infants, children, and adults: a critical review of the literature. Intensive Care Medicine 2013, 39:247-257.
31. Lightowler J.V., Wedzicha J.A., Elliott M.W., Ram F.S.F. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. British Medical Journal 2003, 326:185-187.
32. Liu Y., Matida E.A., Gu J., Johnson M.R. Numerical simulation of aerosol deposition in a 3-D human nasal cavity using RANS, RANS/EIM, and LES. Aerosol Science 2007, 38:683-700.
33. Liu Y., Johnson M.R., Matida E.A., Kherani S., Marsan J. Creation of a standardized geometry of the human nasal cavity. Journal of Applied Physiology 2009, 106:784-795.
34. Longest P.W., Hindle M., Das Choudhuri S., Byron P.R. Numerical simulations of capillary aerosol generation: CFD model development and comparisons with experimental data. Aerosol Science and Technology 2007, 41:952-973.
35. Longest P.W., Vinchurkar S. Effects of mesh style and grid convergence on particle deposition in bifurcating airway models with comparisons to experimental data. Medical Engineering and Physics 2007, 29:350-366.
36. Longest P.W., Xi J. Condensational growth may contribute to the enhanced deposition of cigarette smoke particles in the upper respiratory tract. Aerosol Science and Technology 2008, 42:579-602.
37. Longest P.W., Hindle M. CFD simulations of enhanced condensational growth (ECG) applied to respiratory drug delivery with comparisons to in vitro data. Journal of Aerosol Science 2010, 41:805-820.
38. Longest P.W., Hindle M. Numerical model to characterize the size increase of combination drug and hygroscopic excipient nanoparticle aerosols. Aerosol Science and Technology 2011, 45:884-899.
39. Longest P.W., Tian G., Hindle M. Improving the lung delivery of nasally administered aerosols during noninvasive ventilation - an application of enhanced condensational growth (ECG). Journal of Aerosol Medicine and Pulmonary Drug Delivery 2011, 24:103-118. http://dx.doi.org/110.1089/jamp.2010.0849.
40. Longest P.W., Hindle M. Condensational growth of combination drug-excipient submicrometer particles: comparison of CFD predictions with experimental results. Pharmaceutical Research 2012, 29:707-721.
41. Longest P.W., Tian G., Li X., Son Y.-J., Hindle M. Performance of combination drug and hygroscopic excipient submicrometer particles from a softmist inhaler in a characteristic model of the airways. Annals of Biomedical Engineering 2012, 40:2596-2610.
42. Longest P.W., Golshahi L., Hindle M. Improving pharmaceutical aerosol delivery during noninvasive ventilation: effects of streamlined components. Annals of Biomedical Engineering 2013, 41:1217-1232.
43. Longest P.W., Walenga R.L., Son Y.-J., Hindle M. High efficiency generation and delivery of aerosols through nasal cannula during noninvasive ventilation. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2013, 26:266-279.
44. Martin A.R., Gleske J., Katz I.M., Hartmann M., Mullinger B., Haussermann S., Caillibotte G., Scheuch G. Laser diffraction characterization of droplet size distributions produced by vibrating mesh nebulization of air and a helium-oxygen mixture. Journal of Aerosol Science 2010, 41.
45. McRobbie D.W., Pritchard S.E., Quest R.A. Studies of the human oropharyngeal airspaces using magnetic resonance imaging. I. Validation of a three-dimensional MRI method for producing ex vivo virtual and physical casts of the oropharyngeal airways during inspiration. Journal of Aerosol Medicine 2003, 16:401-415.
46. McRobbie D.W., Pritchard S.E. Studies of the human oropharyngeal airspaces using magnetic resonance imaging. III. The effects of device resistance with forced maneuver and tidal breathing on upper airway geometry. Journal of Aerosol Medicine 2005, 18:325-336.
47. Parke R.L., McGuinness S.P., Eccleston M.L. A preliminary randomized controlled trial to assess effectiveness of nasal high-flow oxygen in intensive care patients. Respiratory Care 2011, 56:265-270.
48. Perry S.A., Kesser K.C., Geller D.E., Selhorst D.M., Rendle J.K., Hertzog J.H. Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system. Pediatric Critical Care Medicine 2013, 14:e250-e256.
49. Pritchard S.E., McRobbie D.W. Studies of the human oropharyngeal airspaces using magnetic resonance imaging. II. The use of three-dimensional gated MRI to determine the influence of mouthpiece diameter and resistance of inhalation devices on the oropharyngeal airspace geometry. Journal of Aerosol Medicine 2004, 17:310-324.
50. Ram F.S., Lightowler J.V., Wedzicha J.A. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2004, 1. CD004104.
51. Rao N., Kadrichu N., Ament B. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2010, 23:295-302.
52. Scherer T., Geller D.E., Owyang L., Tservistas M., Keller M., Boden N., Kesser K.C., Shire S.J. A technical feasibility study of dornase alfa delivery with eFlow® vibrating membrane nebulizers: aerosol characteristics and physicochemical stability. Journal of Pharmaceutical Sciences 2011, 100:98-109.
53. Schroeter J.D., Kimbell J.S., Asgharian B. Analysis of particle deposition in the turbinate and olfactory regions using a human nasal computational fluid dynamics model. Journal of Aerosol Medicine 2006, 19:301-313.
54. Schroeter J.D., Garcia G.J.M., Kimbell J.S. Effects of surface smoothness on inertial particle deposition in human nasal models. Journal of Aerosol Science 2011, 42:52-63.
55. Schwab R.J., Gefter W.B., Pack A.I., Hoffman E.A. Dynamic imaging of the upper airway during respiration in normal subjects. Journal of Applied Physiology 1993, 74:1504-1514.
56. Segal R.A., Kepler G.M., Kimbell J.S. Effects of differences in nasal anatomy of airflow distribution: a comparison of four individuals at rest. Annals of Biomedical Engineering 2008, 36:1870-1882.
57. Shanley K.T., Zamankhan P., Ahmadi G., Hopke P.K., Cheng Y.S. Numerical simulations investigating the regional and overall deposition efficiency of the human nasal cavity. Inhalation Toxicology 2008, 20:1093-1100.
58. Shen X., Hindle M., Byron P.R. Effect of energy on propylene glycol aerosols using the capillary aerosol generator. International Journal of Pharmaceutics 2004, 275:249-258.
59. Stahlhofen W., Rudolf G., James A.C. Intercomparison of experimental regional aerosol deposition data. Journal of Aerosol Medicine 1989, 2:285-308.
60. Storey-Bishoff J., Noga M., Finlay W.H. Deposition of micrometer-sized aerosol particles in infant nasal airway replicas. Aerosol Science 2008, 39:1055-1065.
61. Swift D.L. Inspiratory inertial deposition of aerosols in human nasal airway replicate casts: implication for the proposed NCRP lung model. Radiation Protection Dosimetry 1991, 38:29-34.
62. Swift D.L., Strong J.C. Nasal deposition of ultrafine 218Po aerosols in human subjects. Journal of Aerosol Science 1996, 27:1125-1132.
63. Taylor D.J., Doorly D.J., Schroter R.C. Inflow boundary profile prescription for numerical simulation of nasal airflow. Journal of the Royal Society Interface 2010, 7:515-527.
64. Tian G., Longest P.W., Su G., Hindle M. Characterization of respiratory drug delivery with enhanced condensational growth (ECG) using an individual path model of the entire tracheobronchial airways. Annals of Biomedical Engineering 2011, 39:1136-1153.
65. Tian G., Longest P.W., Li X., Hindle M. Targeting aerosol deposition to and within the lung airways using excipient enhanced growth. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2013, 26:248-265.
66. Trudo F.J., Gefter W.B., Welch K.C., Gupta K.B., Maislin G., Schwab R.J. State-related changes in upper airway caliber and surrounding soft-tissue structures in normal subjects. American Journal of Respiratory and Critical Care Medicine 1998, 158:1259-1270.
67. Van Holsbeke C.S., Stijn L.V., Wim G.V., De Backer J.W., Vinchurkar S.C., Verdonck P.R., van Doorn J.W.D., Nadjmi N., De Backer W.A. Change in upper airway geometry between upright and supine position during tidal nasal breathing. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2013, 26:1-7.
68. Vinchurkar S., Longest P.W. Evaluation of hexahedral, prismatic and hybrid mesh styles for simulating respiratory aerosol dynamics. Computers and Fluids 2008, 37:317-331.
69. Walenga R.L. CFD Assessment of Respiratory Drug Delivery Efficiency in Adults and Improvements Using Controlled Condensational Growth 2014, Virginia Commonwealth University, Richmond, VA.
70. Xi J., Longest P.W. Effects of oral airway geometry characteristics on the diffusional deposition of inhaled nanoparticles. ASME Journal of Biomechanical Engineering 2008, 130:011008.
71. Xi J., Longest P.W. Numerical predictions of submicrometer aerosol deposition in the nasal cavity using a novel drift flux approach. International Journal of Heat And Mass Transfer 2008, 51:5562-5577.
72. Xi J., Longest P.W., Martonen T.B. Effects of the laryngeal jet on nano- and microparticle transport and deposition in an approximate model of the upper tracheobronchial airways. Journal of Applied Physiology 2008, 104:1761-1777.
73. Xi J., Si X.H., Kim J.W., Berlinski A. Simulation of airflow and aerosol deposition in the nasal cavity of a 5-year-old child. Journal of Aerosol Science 2011, 42:156-173.
74. Xi J., Berlinski A., Zhou Y., Greenberg B., Ou X.W. Breathing resistance and ultrafine particle deposition in nasal-laryngeal airways of a newborn, an infant, a child, and an adult. Annals of Biomedical Engineering 2012, 40:2579-2595.
75. Yokley T.R. The functional and adaptive significance of anatomical variation in recent and fossil human nasal passages 2006, (Unpublished Doctoral Dissertation), Duke University, Durham, NC.
76. Zhu J.H., Lee H.P., Lim K.M., Lee S.J., Wang D.Y. Evaluation and comparison of nasal airway flow patterns among three subjects from Caucasian, Chinese and Indian ethnic groups using computational fluid dynamics simulation. Respiratory Physiology & Neurobiology 2011, 175:62-69.